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INTRODUCTION 
The ability to appropriately manage medications is 
crucial to assure medical adherence, particularly in 
older adults with multiple morbidities and regimens with 
several drugs. Older adults usually take an average of 
seven drugs per day; however, up to 40% fail to take 
their medications as prescribed 1 2. 
Adhering to a drug regimen is a complex task that in-
cludes cognitive, physical, functional and socioeconom-
ic abilities. Several instruments have been developed to 
assess medication management ability in patients who 
used their own medications or participated in a simu-
lated medication regimen 3-6.
The DRUGS and Med MaiDe instruments 5 6 both use 
a patients’ own medications and show adequate intra 
and inter-rater reliability, Moreover, the DRUGS tool is 
correlated with cognitive function, responsiveness to 
change, and applicability in different clinical settings 7-11. 
No systematic assessment of drug management ability 
has been implemented into routine clinical practice. 
To fill this gap in knowledge, the present study assessed 
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the medical management ability of hospitalized elderly 
patients and the main clinical factors associated with 
potential inability to manage drugs.
SUBJECTS AND METHODS 
In total, 100 consecutive patients admitted to the Os-
pedale Policlinico San Martino, Geriatric unit, Genoa, 
Italy (January-June 2017) were enrolled. Thirty patients 
were excluded for clinical instability, six patients died, 
ten patients refused to participate in the study, and 
eight patients withdrew from the study. Thus, 46 pa-
tients entered the study after written informed consent 
was obtained. The local ethics committee approved 
this study.
Patients were included if they were: >  65 years, suf-
fering from moderate multiple morbidities (CIRS < 6) 12, 
clinically stable and the hospital discharge drug regi-
men included the target drug packaging (see above). 
Exclusion criteria were end stage chronic disease, 
(CIRS > 6) and an inability to participate in the study.
Demographic variables, residence, marital status, 
and in-home assistance data were collected. All pa-
tients received abbreviated comprehensive geriatric 
assessment, including the following tools to assess 
clinical domains: cognitive status (Mini Mental State 
Examination 13, MMSE), psychological status (Geriatric 
Depression scale  14, GDS 15-items), functional status 
(Basic and Instrumental Activities of Daily Living of Law-
ton  15  16, BADL and IADL), physical burden of illness 
(Cumulative Illness Rating Scale 12, CIRS: Illness Sever-
ity Index-SI, and Co-morbidity Index-CI). A hand-grip 
dynamometer (Camry; EH101 Units: kg/libbers. Maxi-
mum capacity 90 kg. Power 2X 1.5 V AAA batteries. 
Tolerance ± 0.5 kg) was used to assess sarcopenia. 
The DRUGS tool 5 was administered 48-72 hours before 
hospital discharge to assess a person’s ability to iden-
tify drugs, to open containers, to take out the correct 
number, and to appropriately verbalize the prescribed 
drug and dose for the following packaging types:
•  pill blister packs;
•  tablets;
•  child resistant closure droplets;
•  insulin (Apidra Solostar) pen;
•  inhaler devices (e.g., Aliflus diskus inhaler; Bretaris 
inhaler). 
STATISTICS
Data are expressed as mean ± standard deviation. The 
non-parametric Pearson’s correlation analysis was used 
to determine the associations between two variables 
(Fig. 1). The non-parametric t-test (Mann-Whitney test) 
was used to estimate differences between two variables. 
The non-parametric Kruskal-Wallis analysis was used to 
estimate differences among three or more variables. A 
p-value < 0.05 was considered significant. Graph Pad 
version 5.0 b software (Graph Pad Software, La Jolla, 
CA, USA) was used to perform the statistical analysis. 
RESULTS
Mean patient (30 females and 16 males) age was 
86.64 ± 1.01 years. 
A total of 71% of patients lived alone at home and 29% 
received home assistance. 
Most patients’ clinical phenotype (Tab. I) was frail, char-
acterized by severe sarcopenia and functional decline.
All patients failed to manage their medication, fulfill-
ing only the first task (e.g., ability to identify drugs) 
of the four requested for each drug package: (Aliflus 
diskus: 1.37  ±  0.19; Bretaris: 1.11  ±  0.19; Apidar 
Solostar: 1.60  ±  0.16; pill blister pack: 2.35  ±  014; 
tablets 1.33  ±  0.17; child resistant closure droplets: 
1.42 ± 0.16).
A negative correlation was observed between age and 
the DRUGS score (n = 46; r = −0.43, p < 0.001). 
In addition, a positive correlation was detected between 
DRUGS, the BADL (n = 46, r = 0.70, p < 0.0001), the 
IADL (n = 46; r = 0.65, p < 0.001), the MMSE (n = 46; 
r = 0.58, p < 0.0001), and hand-grip strength (n = 46; 
r = 0.42, p < 0.005). Worsening of the DRUGS score 
was associated with the severity of cognitive deficit 
(moderate dementia: MMSE 19-11 points) (KW 12.84 
p  <  0.01) and (severe dementia: MMSE  ≤  10 points) 
(KW 29.91 p < 0.001), respectively. 
Similarly, a moderate functional decline (BADL  <  4/6 
points) was associated with worsening of the DRUGS 
score (U 497: p < 0.01). 
Handgrip strength < 9 kg correlated with worsening of 
the DRUGS score (U 338; p < 0.005).
Table I. Patients’ clinical characteristics based on the abbrevi-
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Multiple morbidities were not associated with impaired 
drug management.
Medication management ability for the Aliflus 
diskus inhaler was inversely correlated with age (n = 46; 
r  =  −0.38, p  <  0.0008) but positively correlated with 
the BADL (n = 46; R = 0.42, p < 0.003), CIRS severity 
Figure 1. Pearson’s correlation analysis between the DRUGs score and age, sarcopenia (hand-grip strength measured in kg), fun-
ctional status (Basic and Instrumental Activities of Daily Living of Lawton, BADL and IADL), and cognitive status (Mini Mental State 
Examination, MMSE).
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(n = 46, r = 0.45, p < 0.0018), the CDT (n = 46, r = −0.36, 
p < 0.001), and the MMSE (n = 46; r = 0.38, p < 0.009). 
Similarly, management ability for the Bretaris inhaler 
was inversely correlated with age (n = 46, r = −0.34, 
p < 0.003) and the MMSE (n = 46, r = 0.51, p < 0.001) 
but positively correlated with the BADL (n = 46, r = 0.54, 
p < 0.005) and the IADL (n = 46, r = 0.60, p < 0.0001). 
In contrast, the medication management ability of child 
resistant closure droplets correlated with hand-grip 
strength (n = 46; r = 0.60, p < 0.0001) as well as the 
Apidra Solostar device (n = 46, r = 0.60, p < 0.0001).
The medication management ability of pill blister packs 
correlated with sarcopenia (n = 46; r = 0.66, p < 0.0001), 
the IADL (n = 46; r = 0.62; p < 0.0001), and cognitive 
status (n = 46; R = 0.43, p < 0.0002). 
DISCUSSION 
Medical management is a highly integrated process that 
includes a defined set of mental and physical skills and 
has also been considered a key to successful aging 17 18 
In contrast, the need to receive assistance with medica-
tions predicts frailty 19-21.
This exploratory study indicates that the ability of elderly 
subjects to manage their medications mainly relies on 
cognitive performance, functional status, and sarcope-
nia 18 19, which are recognized markers of frailty.
In particular, the present findings show that age (oldest-
old population) was the main determinant of the inability 
to manage drugs.
In addition, sarcopenia was associated with an overall 
worsening of drug management ability and was associ-
ated with less ability to use pill blister packs, children 
closure droplets, and an insulin pen.
The use of inhaler devices unmasks higher integrated 
processing; indeed, the inability to use an inhaler was 
associated with cognitive deficit, visuospatial impair-
ment, severity of comorbidities, and functional decline. 
Notably, drug management ability declined according to 
dementia severity and disability as well. Frailty hallmarks 
are key determinants of effective medical management 
performance, adherence, and compliance, with direct 
implications for appropriate clinical management of 
such a vulnerable population. 
Interestingly, multiple morbidities and multiple drug regi-
mens were not associated with drug management abil-
ity. Thus, it could be hypothesized that understanding 
of comorbidity clusters and/or disease severity could 
better help stratify older adults’ higher risk of drug non-
compliance. Similarly, particular types of drugs packag-
ing and the complexity of drugs prescriptions, instead 
of the mere cumulative number of drugs, may primarily 
account for this impaired ability 21 22.
The limitations of this study are the small size and 
the single hospital setting with selection bias and 
underpowered results. Hospital complications, such 
as delirium and exceedingly poor mobility, may ham-
per overall drug management ability. Furthermore, a 
patient’s usual drug regimen may undergo changes 
with which patients may be initially unfamiliar. Even if 
patients verbalized their difficulty taking such a large 
number of medications, no systematic survey has been 
conducted to assess preferences and knowledge of 
medical management strategies. 
The strengths of this study are the real-world assess-
ment of hospitalized oldest-old patients, considering 
a frail clinical phenotype, and the performance-based 
analysis of a broad set of drugs types and packaging. 
Hypothetically, a longitudinal assessment, sample size 
implementation, and a multivariate analysis could add 
knowledge to this field. In particular, including a wider 
set of drugs types and a sub-analysis of specific abilities 
for more complex devices, such as inhalers, could help 
in the understanding of this true geriatric syndrome.
Further research is needed to select the most predictive 
clinical parameters to intercept early drug management 
inability and to assure appropriate drug compliance in 
vulnerable older patients. 
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